Investigatory pathway and principles of patient selection for epilepsy surgery candidates: a systematic review

BACKGROUND: The predominant treatment for epilepsy is pharmacotherapy, yet 20–40% do not respond to anti-epileptic drugs. After becoming pharmacoresistant, some patients are worked-up to determine candidacy for epilepsy surgery. Despite the 2009 American Epilepsy Society guidelines, there is no broa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaffari-Rafi, Arash, Leon-Rojas, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079385/
https://www.ncbi.nlm.nih.gov/pubmed/32183734
http://dx.doi.org/10.1186/s12883-020-01680-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079385/
https://www.ncbi.nlm.nih.gov/pubmed/32183734
http://dx.doi.org/10.1186/s12883-020-01680-w

Ejemplares similares